BRIEF-Adocia and Lilly report positive Phase 1b results on post-meal effect of ultra-rapid BioChaperone Lispro
June 26, 2015 at 02:08 AM EDT
* Announced completion of a Phase 1b clinical trial evaluating BioChaperone lispro, an ultra-rapid formulation of insulin Lispro licensed to Lilly
